Adalimumab-aacf (2 Pen) Coupons & Savings Card – Discount Prices from $915.69
My prescription
Edit
40MG/0.8ML, Adalimumab-aacf (2 Pen) (1 Auto-injector Kit)
Select pharmacy
Albertsons
$915.69
COUPON PRICE
Walgreens
$925.16
COUPON PRICEAdalimumab-aacf (2 Pen) savings card
Show this card to your pharmacistAlbertsons
$915.69
BIN
ID
PCN
GRP
015995
LHKKN669767
GDC
DR33
Powered by
Price history for Adalimumab-aacf (2 Pen) (generic)
1, 40MG/0.8ML
Average retail price for Adalimumab-aacf (2 Pen)
Average SaveHealth price for Adalimumab-aacf (2 Pen)
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
We analyzed Adalimumab-aacf (2 Pen) prices for (40MG/0.8ML, 1 Auto-injector Kit) over the last 12 months. The average retail price was $3277.30, while the average price using the SaveHealth discount card was $910.92. That's a savings of approximately 72.21% when using our Adalimumab-aacf (2 Pen) coupon.
Adalimumab-aacf (2 Pen) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 40MG/0.8ML | 1 Auto-injector Kit | $925.16 | $925.16 |
Adalimumab-aacf (2 Pen) Warnings
Adalimumab-aacf is a medication that modulates the immune system, which can increase the risk of certain health issues. One significant concern is the heightened susceptibility to serious infections, including tuberculosis (TB), bacterial sepsis, and invasive fungal infections like histoplasmosis. Patients should be tested for latent TB before starting treatment and monitored for active TB during therapy. If a serious infection develops, discontinuing the medication is advised.
Another risk involves the potential for developing malignancies, such as lymphoma and other cancers. There have been reports of a rare and aggressive type of T-cell lymphoma, known as hepatosplenic T-cell lymphoma, particularly in adolescents and young adults with inflammatory bowel disease who were treated with tumor necrosis factor (TNF) blockers, including adalimumab products.
Patients with chronic hepatitis B virus (HBV) infection may experience reactivation of the virus, which can be severe and even fatal. It's important to evaluate patients for HBV before initiating therapy and to monitor carriers during and after treatment. If HBV reactivation occurs, stopping the medication and starting antiviral therapy is recommended.
There have been rare cases of new or worsening demyelinating diseases, such as multiple sclerosis and Guillain-Barré syndrome, associated with the use of TNF blockers. Caution is advised when considering this treatment for patients with existing or recent-onset demyelinating disorders.
Serious allergic reactions, including anaphylaxis and angioedema, have been reported. If a severe allergic reaction occurs, the medication should be discontinued immediately, and appropriate therapy should be initiated.
In some instances, treatment has led to the formation of autoantibodies and, rarely, the development of a lupus-like syndrome. If symptoms suggestive of this syndrome appear, discontinuing the medication is recommended.
Patients with heart failure should use this medication with caution, as worsening or new onset of congestive heart failure has been observed. Careful monitoring is essential in these cases.
It's also important to note that live vaccines should not be administered to patients receiving this treatment. Pediatric patients should, if possible, be up to date with all immunizations before starting therapy.
Given these potential risks, it's crucial for patients to discuss their medical history and any concerns with their healthcare provider before starting adalimumab-aacf therapy.
Adalimumab-aacf (2 Pen) Side Effects
When using the Adalimumab-aacf 2 Pen, it's important to be aware of potential side effects. Common reactions include redness, itching, pain, or swelling at the injection site. These symptoms are usually mild and tend to resolve within a few days. To minimize discomfort, allow the pen to reach room temperature before injection and rotate injection sites with each dose. Some individuals may experience upper respiratory infections, such as sinusitis, as well as headaches or rashes. If these symptoms persist or worsen, consult your healthcare provider. Serious side effects, though less common, require immediate medical attention. These include signs of infection like persistent sore throat, cough, fever, chills, night sweats, or difficulty breathing. Additionally, be alert for symptoms such as unusual bruising or bleeding, pale skin, or signs of liver problems like yellowing of the skin or eyes, dark urine, or persistent nausea and vomiting. Rarely, severe allergic reactions can occur, characterized by hives, difficulty breathing, or swelling of the face, lips, or throat. If you experience any of these symptoms, seek emergency medical care immediately. Always discuss any concerns or unusual symptoms with your healthcare provider to ensure safe and effective use of Adalimumab-aacf.
Adalimumab-aacf (2 Pen) Interactions
What is adalimumab-aacf?
Adalimumab-aacf is a biosimilar to adalimumab, which is a medication used to treat various autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and Crohn's disease. Biosimilars are highly similar to an already approved biologic product, with no clinically meaningful differences in terms of safety, purity, and potency.
How much does adalimumab-Aacf cost?
The cost of adalimumab-Aacf can vary significantly depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or patient assistance programs. It is recommended to check with local pharmacies or healthcare providers for the most accurate and up-to-date pricing information. Additionally, patients may want to contact their insurance provider to understand their coverage and potential out-of-pocket costs.
What should I avoid while on adalimumab?
While taking adalimumab, it is important to avoid certain things to ensure safety and effectiveness. Patients should avoid receiving live vaccines, as adalimumab can weaken the immune system and increase the risk of infections. Additionally, they should avoid close contact with people who have infections, as their ability to fight infections may be compromised. It is also advisable to avoid activities that may increase the risk of injury or bleeding, as adalimumab can affect blood clotting. Always consult with a healthcare provider for personalized advice.
What can you not take with adalimumab?
Adalimumab should not be taken with certain medications and substances that can increase the risk of infections or other adverse effects. These include:1. Live vaccines: Patients should avoid receiving live vaccines while on adalimumab, as it can weaken the immune system.2. Other biologic drugs: Combining adalimumab with other biologic agents that suppress the immune system, such as anakinra or abatacept, is generally not recommended.3. Immunosuppressants: Caution is advised when using adalimumab with other immunosuppressive drugs, as this can increase the risk of infections.Patients should always consult their healthcare provider before starting any new medications or supplements while on adalimumab.
Does adalimumab cause weight gain?
Adalimumab is not commonly associated with weight gain as a side effect. However, individual responses to medication can vary, and some patients may experience changes in weight. If there are concerns about weight changes while taking adalimumab, it is advisable to consult with a healthcare provider for personalized advice and management.